Abstract
Cervical cancer is the third most common cause of cancer in women. The 5-year survival rate in oropharyngeal squamous cell carcinomas is approximately 50% and this rate has not improved in recent decades. These cancers are accessible to direct intervention. We examined the ability of a highly efficient non-viral vector, TransfeX (ATCC, Manassas, VA, USA), to deliver the suicide gene HSV-tk to cervical, oral and pharyngeal cancer cells and to induce cytotoxicity following the administration of the prodrug, ganciclovir. HeLa cervical carcinoma, HSC-3 and H357 oral squamous cell carcinoma and FaDu pharyngeal carcinoma cells were transfected with cytomegalovirus (CMV)- or enhanced episomal vector (EEV)-driven HSV-tk plasmids and treated with ganciclovir for 24-120 h. Cell viability was assessed by Alamar blue. The viability of HeLa cells was reduced to only 30-40%, despite the very high levels of transgene expression. By contrast, the viability of HSC-3 cells was reduced to 10%, although transgene expression was 18-fold lower than that in HeLa cells. An approximately five-fold higher transgene expression was obtained with the EEV-plasmid than from the CMV-plasmid. Nevertheless, HeLa cell viability after suicide gene + ganciclovir t...Continue Reading
References
Jul 1, 1996·The Annals of Otology, Rhinology, and Laryngology·E A GoebelJ A Kern
Jul 24, 1996·Biochimica Et Biophysica Acta·K KonopkaN Düzgüneş
Feb 17, 2000·Biochimica Et Biophysica Acta·C Tros de Ilarduya, N Düzgüneş
Feb 17, 2000·Biochimica Et Biophysica Acta·S SimõesN Düzgüneş
Aug 30, 2000·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·S C Shin, J Y Kim
Mar 28, 2001·The Journal of Gene Medicine·L A WangerekS M Forrest
Apr 5, 2001·Oral Oncology·T FukuiJ Yoshida
Apr 20, 2001·Advanced Drug Delivery Reviews·M C Pedroso de LimaN Düzgüneş
Dec 19, 2002·Biochimica Et Biophysica Acta·H FanecaM C Pedrosa de Lima
Apr 14, 2004·The Journal of Gene Medicine·Marika RuponenArto Urtti
Apr 29, 2004·International Journal of Pharmaceutics·Wenhao LiHiroshi Kiwada
Oct 20, 2006·Biochimica Et Biophysica Acta·Sílvia S NevesMaria C Pedroso de Lima
Aug 12, 2008·Cancer Gene Therapy·S NevesM C Pedroso de Lima
Nov 20, 2009·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Gabi U DachsAdam V Patterson
Nov 9, 2010·BMC Cancer·Daozhen Chen, Qiusha Tang
Apr 1, 2014·International Journal of Clinical Oncology·Ken Omura
Oct 11, 2014·World Journal of Clinical Oncology·Shaniqua L McGraw, Jeanne M Ferrante
Jan 1, 2014·Molecular Therapy. Methods & Clinical Development·Patrick F FordeDeclan M Soden
Jul 29, 2015·CA: a Cancer Journal for Clinicians·Angela C ChiBrad W Neville
Nov 26, 2015·Oncogene·S M ParselS M Thomas
Oct 30, 2016·Therapeutic Delivery·Jennifer CheungNejat Düzgünes